About Pathogenics Inc.

Pathogenics Inc. is currently developing N-Chlorotaurine (NCT) as a novel anti-infective/anti-inflammatory medicine for the treatment of COVID-19 in mild to severe cases.


NCT helps fight COVID-19 by directly killing the SARS-CoV-2 virus, controlling inflammation, preventing secondary infections/thrombosis, and protecting living cells by supplying an essential antioxidant through its primary byproduct, the amino acid taurine.

Unlike antibiotics or vaccines (antibodies) which only target specific pathogens, the non-specific way NCT kills pathogens prevents them from ever becoming resistant to it.

N-Chlorotaurine (NCT)

NCT occurs naturally in the human body, where it is created by white blood cells to kill invading pathogens, and to control and terminate the body’s inflammatory response.

NCT is effective against virtually all pathogens including bacteria, viruses, fungi, and protozoa. After it kills a pathogen, NCT breaks down into essential substances already found in the human body, and therefore it is non-toxic and does not cause allergic reactions.

NCT is pharmaceutically synthesized as a sodium salt, which readily dissolves in water to formulate a topical antiseptic medication that is exceptionally safe and tolerable.

NCT Interview: Anti-COVID Therapies – New Research and Mechanisms of Action